| P50 | author | Magali Saint-Geniez | Q58898025 |
| | Michel Jean Robert Perricaudet | Q64398414 |
| P2093 | author name string | M. Menasche | |
| | D. Marchant | |
| | M. Perricaudet | |
| | A. Provost | |
| | M. Abitbol | |
| | L. Le Gat | |
| | K. Gogat | |
| | C. Bouquet | |
| | D. Darland | |
| | L. Van Den Berghe | |
| P2860 | cites work | Investigative Ophthalmology Visual Science | Q6060707 |
| | Blindness caused by diabetic retinopathy | Q69781866 |
| | Endostatin induces endothelial cell apoptosis | Q77335987 |
| | Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents | Q78365092 |
| | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 |
| | Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization | Q28203561 |
| | Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization | Q31081886 |
| | Cloning, expression, and in vitro activity of human endostatin | Q33862216 |
| | Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization | Q34749337 |
| | Gene therapy for ocular angiogenesis. | Q35061497 |
| | Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization | Q35745444 |
| | Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. | Q35897076 |
| | Recombinational construction in Escherichia coli of infectious adenoviral genomes | Q35997183 |
| | Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate | Q36868245 |
| | The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 |
| | Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding | Q40935045 |
| | Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies | Q41607468 |
| | Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. | Q43852725 |
| | Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. | Q44763476 |
| | Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice | Q44839939 |
| | Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice | Q45858195 |
| | Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis | Q45883663 |
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetics | Q7162 |
| | Adenoviridae | Q193447 |
| | neovascularization | Q1281049 |
| | molecular medicine | Q3523816 |
| P304 | page(s) | 2098-2103 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy | |
| P478 | volume | 10 | |